Cobicistat
Cobicistat is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Pharmacokinetic enhancement compound used with ATV, DRV (800 mg once daily only) or EVG
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: April 6, 2016
Citation
Smith, Janessa M. "Cobicistat." Johns Hopkins HIV Guide, 2016. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545248/all/Cobicistat.
Smith JM. Cobicistat. Johns Hopkins HIV Guide. 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545248/all/Cobicistat. Accessed August 25, 2019.
Smith, J. M. (2016). Cobicistat. In Johns Hopkins HIV Guide. Available from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545248/all/Cobicistat
Smith JM. Cobicistat [Internet]. In: Johns Hopkins HIV Guide. ; 2016. [cited 2019 August 25]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545248/all/Cobicistat.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cobicistat
ID - 545248
A1 - Smith,Janessa,PharmD, BCPS
Y1 - 2016/04/06/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545248/all/Cobicistat
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -